Polycystic ovary syndrome (original) (raw)

• Stepto, N. K. et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum. Reprod. 28, 777–784 (2013).
  Article CAS PubMed Google Scholar
• Vink, J. M., Sadrzadeh, S., Lambalk, C. B. & Boomsma, D. I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J. Clin. Endocrinol. Metab. 91, 2100–2104 (2006). This study clearly demonstrates the very high heritability of PCOS through twin studies.
  Article CAS PubMed Google Scholar
• Azziz, R., Marin, C., Hoq, L., Badamgarav, E. & Song, P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J. Clin. Endocrinol. Metab. 90, 4650–4658 (2005).
  Article CAS PubMed Google Scholar
• Diamanti-Kandarakis, E., Spritzer, P. M., Sir-Petermann, T. & Motta, A. B. Insulin resistance and polycystic ovary syndrome through life. Curr. Pharm. Des. 18, 5569–5576 (2012).
  Article CAS PubMed Google Scholar
• Lizneva, D. et al. The criteria, prevalence and phenotypes of PCOS. Fertil. Steril. 106, 6–15 (2016).
  Article PubMed Google Scholar
• Zawadzki, J. & Duniaf, A. in Polycystic Ovary Syndrome (eds Dunaif, A., Givens, J. R., Haseltine, F. P. & Merriam, G. R. ) 377–384 (Blackwell Scientific Publications, 1992).
  Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 19, 41–47 (2004).
  Article Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19–25 (2004).
  Google Scholar
• Ezeh, U., Yildiz, B. O. & Azziz, R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 98, E1088–E1096 (2013). This is the first study to clearly demonstrate that the phenotype of PCOS observed in clinical studies may be very different from that observed in medically unbiased populations, indicating the need to better understand the true phenotype of PCOS.
  Article CAS PubMed PubMed Central Google Scholar
• Azziz, R. et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil. Steril. 91, 456–488 (2009).
  Article PubMed Google Scholar
• DeUgarte, C. M., Woods, K. S., Bartolucci, A. A. & Azziz, R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J. Clin. Endocrinol. Metab. 91, 1345–1350 (2006).
  Article CAS PubMed Google Scholar
• Souter, I., Sanchez, L. A., Perez, M., Bartolucci, A. A. & Azziz, R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am. J. Obstet. Gynecol. 191, 1914–1920 (2004).
  Article CAS PubMed Google Scholar
• Dunaif, A., Segal, K. R., Futterweit, W. & Dobrjansky, A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165–1174 (1989). This is one of the first studies to conclusively demonstrate that women with PCOS have significant insulin resistance that is independent of obesity, changes in body composition and impairment of glucose tolerance, and that hyperinsulinaemia in PCOS is not the result of decreased insulin clearance.
  Article CAS PubMed Google Scholar
• Moran, L. J., Misso, M. L., Wild, R. A. & Norman, R. J. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 16, 347–363 (2010).
  Article CAS PubMed Google Scholar
• Legro, R. S., Gnatuk, C. L., Kunselman, A. R. & Dunaif, A. Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study. J. Clin. Endocrinol. Metab. 90, 3236–3242 (2005).
  Article CAS PubMed Google Scholar
• Norman, R. J., Masters, L., Milner, C. R., Wang, J. X. & Davies, M. J. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum. Reprod. 16, 1995–1998 (2001).
  Article CAS PubMed Google Scholar
• Hudecova, M. et al. Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome — a long term follow-up. Hum. Reprod. 26, 1462–1468 (2011).
  Article CAS PubMed Google Scholar
• Gambineri, A. et al. Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study. Diabetes 61, 2369–2374 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Schmidt, J., Landin-Wilhelmsen, K., Brannstrom, M. & Dahlgren, E. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study. J. Clin. Endocrinol. Metab. 96, 3794–3803 (2011).
  Article CAS PubMed Google Scholar
• Lim, S. S., Davies, M. J., Norman, R. J. & Moran, L. J. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. Update 18, 618–637 (2012).
  Article CAS PubMed Google Scholar
• Luque-Ramirez, M. et al. Referral bias in female functional hyperandrogenism and polycystic ovary syndrome. Eur. J. Endocrinol. 173, 603–610 (2015).
  Article CAS PubMed Google Scholar
• Guyatt, G., Weaver, B., Cronin, L., Dooley, J. A. & Azziz, R. Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated. J. Clin. Epidemiol. 57, 1279–1287 (2004).
  Article PubMed Google Scholar
• Khomami, M. B., Tehrani, F. R., Hashemi, S., Farahmand, M. & Azizi, F. Of PCOS symptoms, hirsutism has the most significant impact on the quality of life of Iranian women. PLoS ONE 10, e0123608 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Dilbaz, B., Cinar, M., Ozkaya, E., Tonyali, N. V. & Dilbaz, S. Health related quality of life among different PCOS phenotypes of infertile women. J. Turk. Ger. Gynecol. Assoc. 13, 247–252 (2012).
  Article PubMed PubMed Central Google Scholar
• Gosman, G. G. et al. Reproductive health of women electing bariatric surgery. Fertil. Steril. 94, 1426–1431 (2010).
  Article PubMed Google Scholar
• Alvarez-Blasco, F., Botella-Carretero, J. I., San Millan, J. L. & Escobar-Morreale, H. F. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch. Intern. Med. 166, 2081–2086 (2006).
  Article PubMed Google Scholar
• Laitinen, J. et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int. J. Obes. Relat. Metab. Disord. 27, 710–715 (2003).
  Article CAS PubMed Google Scholar
• Teede, H. J. et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity (Silver Spring) 21, 1526–1532 (2013).
  Article Google Scholar
• Yildiz, B. O., Knochenhauer, E. S. & Azziz, R. Impact of obesity on the risk for polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93, 162–168 (2008).
  Article CAS PubMed Google Scholar
• Yildiz, B. O., Bozdag, G., Yapici, Z., Esinler, I. & Yarali, H. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum. Reprod. 27, 3067–3073 (2012).
  Article PubMed Google Scholar
• Ewens, K. G. et al. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS ONE 6, e16390 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Cai, X., Liu, C. & Mou, S. Association between fat mass- and obesity-associated (FTO) gene polymorphism and polycystic ovary syndrome: a meta-analysis. PLoS ONE 9, e86972 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Louwers, Y. V. et al. BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case–control study. PLoS ONE 9, e87335 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Joham, A. E., Teede, H. J., Ranasinha, S., Zoungas, S. & Boyle, J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J. Womens Health (Larchmt) 24, 299–307 (2015).
  Article Google Scholar
• Wild, S., Pierpoint, T., Jacobs, H. & McKeigue, P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum. Fertil. (Camb.) 3, 101–105 (2000).
  Article Google Scholar
• Teede, H. J. et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med. J. Aust. 195, S65–112 (2011).
  Article PubMed Google Scholar
• Dokras, A., Clifton, S., Futterweit, W. & Wild, R. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstetr. Gynecol. 117, 145–152 (2011).
  Article Google Scholar
• Veltman-Verhu lst, S. M., Boivin, J., Eijkemans, M. J. & Fauser, B. J. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum. Reprod. Update 18, 638–651 (2012).
  Article Google Scholar
• Moran, L. J., Deeks, A. A., Gibson-Helm, M. E. & Teede, H. J. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum. Reprod. 27, 2082–2088 (2012).
  Article CAS PubMed Google Scholar
• Cinar, N. et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum. Reprod. 26, 3339–3345 (2011).
  Article PubMed Google Scholar
• Roos, N. et al. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. BMJ 343, d6309 (2011).
  Article PubMed PubMed Central Google Scholar
• Sterling, L. et al. Pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization. Fertil. Steril. 105, 791–797.e2 (2016).
  Article PubMed Google Scholar
• Pan, M. L., Chen, L. R., Tsao, H. M. & Chen, K. H. Relationship between polycystic ovarian syndrome and subsequent gestational diabetes mellitus: a nationwide population-based study. PLoS ONE 10, e0140544 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Palomba, S. et al. Pregnancy complications in women with polycystic ovary syndrome. Hum. Reprod. Update 21, 575–592 (2015).
  Article PubMed Google Scholar
• Vanky, E. et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J. Clin. Endocrinol. Metab. 95, E448–E455 (2010). This is the first study to clearly demonstrate that metformin treatment from the first trimester to delivery did not reduce pregnancy complications in women with PCOS.
  Article CAS PubMed Google Scholar
• Carmina, E. Polycystic ovary syndrome: metabolic consequences and long-term management. Scand. J. Clin. Lab. Invest. Suppl. 244, 23–26; discussion 26 (2014).
  Article CAS PubMed Google Scholar
• Christian, R. C. et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88, 2562–2568 (2003).
  Article CAS PubMed Google Scholar
• Talbott, E. O. et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 89, 5454–5461 (2004).
  Article CAS PubMed Google Scholar
• Luque-Ramirez, M., Mendieta-Azcona, C., Alvarez-Blasco, F. & Escobar-Morreale, H. F. Androgen excess is associated with the increased carotid intima–media thickness observed in young women with polycystic ovary syndrome. Hum. Reprod. 22, 3197–3203 (2007).
  Article CAS PubMed Google Scholar
• Lass, N., Kleber, M., Winkel, K., Wunsch, R. & Reinehr, T. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima–media thickness in obese adolescent girls. J. Clin. Endocrinol. Metab. 96, 3533–3540 (2011).
  Article CAS PubMed Google Scholar
• Chang, A. Y. et al. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin. Endocrinol. (Oxf.) 74, 89–96 (2011).
  Article CAS Google Scholar
• Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L. & Oden, A. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet. Gynecol. Scand. 71, 599–604 (1992).
  Article CAS PubMed Google Scholar
• Carmina, E., Campagna, A. M. & Lobo, R. A. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors. Hum. Reprod. 28, 2245–2252 (2013).
  Article CAS PubMed Google Scholar
• Ramezani Tehrani, F. et al. Trend of cardio-metabolic risk factors in polycystic ovary syndrome: a population-based prospective cohort study. PLoS ONE 10, e0137609 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Bairey Merz, C. N. et al. Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of PCOS. J. Womens Health (Larchmt) 6 June 2016 [epub ahead of print].
  Google Scholar
• Hart, R. & Doherty, D. A. The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage. J. Clin. Endocrinol. Metab. 100, 911–919 (2015).
  Article CAS PubMed Google Scholar
• Cibula, D. et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum. Reprod. 15, 785–789 (2000).
  Article CAS PubMed Google Scholar
• Mani, H. et al. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin. Endocrinol. (Oxf.) 78, 926–934 (2013).
  Article Google Scholar
• Krentz, A. J., von Muhlen, D. & Barrett-Connor, E. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose–effect association with prevalent cardiovascular disease. Menopause 14, 284–292 (2007).
  Article PubMed PubMed Central Google Scholar
• Wild, S., Pierpoint, T., McKeigue, P. & Jacobs, H. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin. Endocrinol. (Oxf.) 52, 595–600 (2000).
  Article CAS Google Scholar
• Iftikhar, S. et al. Risk of cardiovascular events in patients with polycystic ovary syndrome. Neth. J. Med. 70, 74–80 (2012).
  CAS PubMed PubMed Central Google Scholar
• Carmina, E. Oral contraceptives and cardiovascular risk in women with polycystic ovary syndrome. J. Endocrinol. Invest. 36, 358–363 (2013).
  CAS PubMed Google Scholar
• Bird, S. T., Hartzema, A. G., Brophy, J. M., Etminan, M. & Delaney, J. A. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ 185, E115–E120 (2013).
  Article PubMed PubMed Central Google Scholar
• Anderson, S. A., Barry, J. A. & Hardiman, P. J. Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: a systematic review and meta-analysis. Int. J. Cardiol. 176, 486–487 (2014).
  Article PubMed Google Scholar
• Carmina, E., Campagna, A. M. & Lobo, R. A. A 20-year follow-up of young women with polycystic ovary syndrome. Obstet. Gynecol. 119, 263–269 (2012).
  Article PubMed Google Scholar
• Dumesic, D. A. & Lobo, R. A. Cancer risk and PCOS. Steroids 78, 782–785 (2013).
  Article CAS PubMed Google Scholar
• Kahsar-Miller, M. & Azziz, R. The development of the polycystic ovary syndrome: family history as a risk factor. Trends Endocrinol. Metab. 9, 55–58 (1998).
  Article CAS PubMed Google Scholar
• Legro, R. S., Driscoll, D., Strauss, J. F. 3rd, Fox, J. & Dunaif, A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc. Natl Acad. Sci. USA 95, 14956–14960 (1998).
  Article CAS PubMed Google Scholar
• Lerchbaum, E., Schwetz, V., Giuliani, A. & Obermayer-Pietsch, B. Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women. Eur. J. Endocrinol. 170, 727–739 (2014).
  Article CAS PubMed Google Scholar
• Kosova, G. & Urbanek, M. Genetics of the polycystic ovary syndrome. Mol. Cell. Endocrinol. 373, 29–38 (2013).
  Article CAS PubMed Google Scholar
• Shi, Y. et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat. Genet. 44, 1020–1025 (2012).
  Article CAS PubMed Google Scholar
• Chen, Z. J. et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat. Genet. 43, 55–59 (2011). This is the first genome-wide association study of PCOS.
  Article CAS PubMed Google Scholar
• Du, J. et al. Family-based analysis of INSR polymorphisms in Chinese PCOS. Reprod. Biomed. Online 29, 239–244 (2014).
  Article CAS PubMed Google Scholar
• Zhao, S. et al. Family-based analysis of eight susceptibility loci in polycystic ovary syndrome. Sci. Rep. 5, 12619 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Hayes, M. G. et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat. Commun. 6, 7502 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Day, F. R. et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat. Commun. 6, 8464 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Azziz, R. PCOS in 2015: new insights into the genetics of polycystic ovary syndrome. Nat. Rev. Endocrinol. 12, 74–75 (2016).
  Article CAS PubMed Google Scholar
• Cui, L. et al. Genotype–phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women. Hum. Reprod. 28, 538–544 (2013).
  Article CAS PubMed Google Scholar
• Welt, C. K. et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J. Clin. Endocrinol. Metab. 97, E1342–E1347 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Saxena, R. et al. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum. Reprod. 30, 1454–1459 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Cui, L. et al. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature. Hum. Reprod. 30, 732–736 (2015).
  Article CAS PubMed Google Scholar
• Shim, U. et al. Pathway analysis based on a genome-wide association study of polycystic ovary syndrome. PLoS ONE 10, e0136609 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Jones, M. R. et al. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 11, e1005455 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Banaszewska, B., Spaczynski, R. Z., Pelesz, M. & Pawelczyk, L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. Rocz. Akad. Med. Bialymst. 48, 131–134 (2003).
  CAS PubMed Google Scholar
• Dale, P. O., Tanbo, T., Vaaler, S. & Abyholm, T. Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: evidence of two distinct populations. Fertil. Steril. 58, 487–491 (1992).
  Article CAS PubMed Google Scholar
• Burt Solorzano, C. M., McCartney, C. R., Blank, S. K., Knudsen, K. L. & Marshall, J. C. Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion. BJOG 117, 143–149 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Dumesic, D. A. et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr. Rev. 36, 487–525 (2015). This paper provides a comprehensive overview of the complexity of PCOS and also provides some useful practical guidelines on how to take care of these patients in daily practice.
  Article CAS PubMed PubMed Central Google Scholar
• Fauser, B. C. & Van Heusden, A. M. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev. 18, 71–106 (1997).
  CAS PubMed Google Scholar
• Broekmans, F. J. et al. Anti-Müllerian hormone and ovarian dysfunction. Trends Endocrinol. Metab. 19, 340–347 (2008).
  Article CAS PubMed Google Scholar
• Valkenburg, O. et al. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum. Reprod. 24, 2014–2022 (2009).
  Article CAS PubMed Google Scholar
• Laven, J. S. et al. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J. Clin. Endocrinol. Metab. 89, 318–323 (2004).
  Article CAS PubMed Google Scholar
• Stubbs, S. A. et al. Anti-Müllerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J. Clin. Endocrinol. Metab. 90, 5536–5543 (2005).
  Article CAS PubMed Google Scholar
• Visser, J. A. et al. Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Müllerian hormone null mice. Endocrinology 148, 2301–2308 (2007).
  Article CAS PubMed Google Scholar
• Catteau-Jonard, S. & Dewailly, D. Pathophysiology of polycystic ovary syndrome: the role of hyperandrogenism. Front. Horm. Res. 40, 22–27 (2013).
  Article CAS PubMed Google Scholar
• Padmanabhan, V. et al. Dynamics of bioactive follicle-stimulating hormone secretion in women with polycystic ovary syndrome: effects of estradiol and progesterone. Fertil. Steril. 75, 881–888 (2001).
  Article CAS PubMed Google Scholar
• Webber, L. J. et al. Formation and early development of follicles in the polycystic ovary. Lancet 362, 1017–1021 (2003).
  Article CAS PubMed Google Scholar
• Nestler, J. E. et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J. Clin. Endocrinol. Metab. 83, 2001–2005 (1998).
  CAS PubMed Google Scholar
• Visser, J. A., Schipper, I., Laven, J. S. & Themmen, A. P. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat. Rev. Endocrinol. 8, 331–341 (2012).
  Article CAS PubMed Google Scholar
• Teixeira Filho, F. L. et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87, 1337–1344 (2002).
  Article CAS PubMed Google Scholar
• Bergman, R. N., Ider, Y. Z., Bowden, C. R. & Cobelli, C. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236, E667–E677 (1979).
  CAS PubMed Google Scholar
• O'Meara, N. M. et al. Defects in beta-cell function in functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 76, 1241–1247 (1993).
  CAS PubMed Google Scholar
• Ehrmann, D. A. et al. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J. Clin. Invest. 96, 520–527 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Dunaif, A. & Finegood, D. T. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 81, 942–947 (1996).
  CAS PubMed Google Scholar
• Diamanti-Kandarakis, E. & Dunaif, A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr. Rev. 33, 981–1030 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pasquali, R. et al. Insulin and C-peptide levels in obese patients with polycystic ovaries. Horm. Metab. Res. 14, 284–287 (1982).
  Article CAS PubMed Google Scholar
• Mahabeer, S. et al. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease. Horm. Metab. Res. 21, 502–506 (1989).
  Article CAS PubMed Google Scholar
• Dunaif, A., Xia, J., Book, C. B., Schenker, E. & Tang, Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J. Clin. Invest. 96, 801–810 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Dunaif, A. et al. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 41, 1257–1266 (1992).
  Article CAS PubMed Google Scholar
• Ciaraldi, T. P. et al. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 75, 577–583 (1992).
  CAS PubMed Google Scholar
• Corbould, A., Zhao, H., Mirzoeva, S., Aird, F. & Dunaif, A. Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55, 751–759 (2006).
  Article CAS PubMed Google Scholar
• Rajkhowa, M. et al. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo. Biochem. J. 418, 665–671 (2009).
  Article CAS PubMed Google Scholar
• Book, C. B. & Dunaif, A. Selective insulin resistance in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 84, 3110–3116 (1999).
  CAS PubMed Google Scholar
• Corbould, A. et al. Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am. J. Physiol. Endocrinol. Metab. 288, E1047–E1054 (2005).
  Article CAS PubMed Google Scholar
• Eriksen, M. et al. Insulin resistance is not conserved in myotubes established from women with PCOS. PLoS ONE 5, e14469 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Ciaraldi, T. P., Aroda, V., Mudaliar, S., Chang, R. J. & Henry, R. R. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J. Clin. Endocrinol. Metab. 94, 157–163 (2009).
  Article CAS PubMed Google Scholar
• Chazenbalk, G. et al. Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-α. J. Clin. Endocrinol. Metab. 95, 935–942 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Manneras-Holm, L. et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J. Clin. Endocrinol. Metab. 96, E304–E311 (2011).
  Article CAS PubMed Google Scholar
• Ek, I., Arner, P., Bergqvist, A., Carlstrom, K. & Wahrenberg, H. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? J. Clin. Endocrinol. Metab. 82, 1147–1153 (1997).
  CAS PubMed Google Scholar
• Rosenbaum, D., Haber, R. S. & Dunaif, A. Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes. Am. J. Physiol. 264, E197–E202 (1993).
  CAS PubMed Google Scholar
• Garvey, W. T. et al. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J. Clin. Invest. 87, 1072–1081 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Carvalho, E., Jansson, P. A., Nagaev, I., Wenthzel, A. M. & Smith, U. Insulin resistance with low cellular IRS-1 expression is also associated with low GLUT4 expression and impaired insulin-stimulated glucose transport. FASEB J. 15, 1101–1103 (2001).
  CAS PubMed Google Scholar
• Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B. & Rondinone, C. M. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes 52, 634–641 (2003).
  Article CAS PubMed Google Scholar
• Chen, Y. H. et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes 62, 2278–2286 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ciaraldi, T. P. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J. Pediatr. Endocrinol. Metab. 13 (Suppl. 5), 1291–1293 (2000).
  PubMed Google Scholar
• Ciaraldi, T. P. et al. Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. J. Clin. Endocrinol. Metab. 82, 1421–1425 (1997).
  CAS PubMed Google Scholar
• Chuang, T. Y. et al. MicroRNA-223 expression is upregulated in insulin resistant human adipose tissue. J. Diabetes Res. 2015, 943659 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• McAllister, J. M., Legro, R. S., Modi, B. P. & Strauss, J. F. 3rd. Functional genomics of PCOS: from GWAS to molecular mechanisms. Trends Endocrinol. Metab. 26, 118–124 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Yildiz, B. O. & Azziz, R. The adrenal and polycystic ovary syndrome. Rev. Endocr. Metab. Disord. 8, 331–342 (2007).
  Article CAS PubMed Google Scholar
• Deeks, A. A., Gibson-Helm, M. E. & Teede, H. J. Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation. Fertil. Steril. 93, 2421–2423 (2010).
  Article PubMed Google Scholar
• Moran, L., Gibson-Helm, M., Teede, H. & Deeks, A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J. Psychosomat. Obstetr. Gynaecol. 31, 24–31 (2010).
  Article Google Scholar
• Gibson-Helm, M. E., Lucas, I. M., Boyle, J. A. & Teede, H. J. Women's experiences of polycystic ovary syndrome diagnosis. Fam. Pract. 31, 545–549 (2014).
  Article PubMed Google Scholar
• Kitzinger, C. & Willmott, J. ‘The thief of womanhood’: women's experience of polycystic ovarian syndrome. Soc. Sci. Med. 54, 349–361 (2002).
  Article PubMed Google Scholar
• Shroff, R., Syrop, C. H., Davis, W., Van Voorhis, B. J. & Dokras, A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil. Steril. 88, 1389–1395 (2007).
  Article CAS PubMed Google Scholar
• Daan, N. M. et al. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Fertil. Steril. 102, 1444–1451.e3 (2014).
  Article PubMed Google Scholar
• Daskalopoulos, G. et al. Excess metabolic and cardiovascular risk is not manifested in all phenotypes of polycystic ovary syndrome: implications for diagnosis and treatment. Curr. Vasc. Pharmacol. 13, 788–800 (2015).
  Article CAS PubMed Google Scholar
• Tehrani, F. R., Rashidi, H., Khomami, M. B., Tohidi, M. & Azizi, F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod. Biol. Endocrinol. 12, 89 (2014).
  Article PubMed Google Scholar
• Ibanez, L., Lopez-Bermejo, A., Diaz, M., Marcos, M. V. & de Zegher, F. Early metformin therapy (age 8–12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence. J. Clin. Endocrinol. Metab. 96, E1262–E1267 (2011).
  Article CAS PubMed Google Scholar
• Legro, R. S. et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 98, 4565–4592 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Fauser, B. C. et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28–38.e25 (2012).
  Article PubMed Google Scholar
• Azziz, R. et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J. Clin. Endocrinol. Metab. 91, 4237–4245 (2006).
  Article CAS PubMed Google Scholar
• Moran, L. J. et al. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome. Hum. Reprod. 30, 466–472 (2015).
  Article CAS PubMed Google Scholar
• Thomson, R. L. et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil. Steril. 94, 1812–1816 (2010).
  Article PubMed Google Scholar
• Moran, L. J., Hutchison, S. K., Norman, R. J. & Teede, H. J. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst. Rev. 7, CD007506 (2011). A meta-analysis of the data reported on lifestyle changes, and summarizes results that may be obtained and problems that arise with this treatment.
  Google Scholar
• Carmina, E. PCOS: metabolic impact and long-term management. Minerva Ginecol. 64, 501–505 (2012).
  CAS PubMed Google Scholar
• Kiddy, D. S. et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 36, 105–111 (1992).
  Article CAS Google Scholar
• Moran, L. J. et al. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 88, 812–819 (2003).
  Article CAS PubMed Google Scholar
• Moran, L. J. et al. Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines. J. Acad. Nutr. Diet. 113, 520–545 (2013).
  Article PubMed Google Scholar
• Goss, A. M. et al. Effects of a eucaloric reduced-carbohydrate diet on body composition and fat distribution in women with PCOS. Metabolism 63, 1257–1264 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Gower, B. A. et al. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin. Endocrinol. (Oxf.) 79, 550–557 (2013).
  Article CAS Google Scholar
• Roessler, K. K., Birkebaek, C., Ravn, P., Andersen, M. S. & Glintborg, D. Effects of exercise and group counselling on body composition and VO2max in overweight women with polycystic ovary syndrome. Acta Obstetricia Gynecol. Scand. 92, 272–277 (2013).
  Article Google Scholar
• Harrison, C. L., Lombard, C. B., Moran, L. J. & Teede, H. J. Exercise therapy in polycystic ovary syndrome: a systematic review. Hum. Reprod. Update 17, 171–183 (2011).
  Article PubMed Google Scholar
• Harrison, C. L., Stepto, N. K., Hutchison, S. K. & Teede, H. J. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 76, 351–357 (2012).
  Article CAS Google Scholar
• Skubleny, D. et al. The impact of bariatric surgery on polycystic ovary syndrome: a systematic review and meta-analysis. Obes. Surg. 26, 169–176 (2016).
  Article PubMed Google Scholar
• Tang, T., Lord, J. M., Norman, R. J., Yasmin, E. & Balen, A. H. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev. 5, CD003053 (2012).
  Google Scholar
• Naderpoor, N. et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum. Reprod. Update 21, 560–574 (2015).
  Article CAS PubMed Google Scholar
• Du, Q. et al. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome. Curr. Med. Res. Opin. 28, 723–730 (2012).
  Article CAS PubMed Google Scholar
• Li, X. J. et al. Metformin versus thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clin. Endocrinol. (Oxf.) 74, 332–339 (2011).
  Article CAS Google Scholar
• Goodman, N. F. et al. American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And PCOS Society Disease State clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome — part 2. Endocr. Pract. 21, 1415–1426 (2015).
  Article PubMed Google Scholar
• Formuso, C., Stracquadanio, M. & Ciotta, L. Myo-inositol versus d-chiro inositol in PCOS treatment. Minerva Ginecol. 67, 321–325 (2015).
  CAS PubMed Google Scholar
• Nestler, J. E. & Unfer, V. Reflections on inositol(s) for PCOS therapy: steps toward success. Gynecol. Endocrinol. 31, 501–505 (2015).
  Article CAS PubMed Google Scholar
• Zhang, Y. Y., Hou, L. Q. & Zhao, T. Y. Effects of acarbose on polycystic ovary syndrome: a meta-analysis. Exp. Clin. Endocrinol. Diabetes 122, 373–378 (2014).
  Article CAS PubMed Google Scholar
• Gao, L., Zhao, F. L. & Li, S. C. Statin is a reasonable treatment option for patients with polycystic ovary syndrome: a meta-analysis of randomized controlled trials. Exp. Clin. Endocrinol. Diabetes 120, 367–375 (2012).
  Article CAS PubMed Google Scholar
• Sun, J. et al. An investigation into the therapeutic effects of statins with metformin on polycystic ovary syndrome: a meta-analysis of randomised controlled trials. BMJ Open 5, e007280 (2015).
  Article PubMed PubMed Central Google Scholar
• Khera, R. et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 315, 2424–2434 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Diamanti-Kandarakis, E., Katsikis, I., Piperi, C., Alexandraki, K. & Panidis, D. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 66, 103–109 (2007).
  CAS Google Scholar
• Jia, X. Z. et al. Effect of vitamin D on clinical and biochemical parameters in polycystic ovary syndrome women: a meta-analysis. J. Obstetr. Gynaecol. Res. 41, 1791–1802 (2015).
  Article CAS Google Scholar
• Mathur, R., Levin, O. & Azziz, R. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome. Ther. Clin. Risk Manag. 4, 487–492 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Conway, G. et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur. J. Endocrinol. 171, 1–29 (2014).
  Article CAS Google Scholar
• Yildiz, B. O. Approach to the patient: contraception in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 100, 794–802 (2015).
  Article CAS PubMed Google Scholar
• Centers for Disease Control and Prevention (CDC). U. S. medical eligibility criteria for contraceptive use, 2010. MMWR Recomm. Rep. 59, 1–86 (2010).
  Google Scholar
• Azziz, R. et al. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J. Clin. Endocrinol. Metab. 80, 3406–3411 (1995).
  CAS PubMed Google Scholar
• Naka, K. K. et al. Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study. Fertil. Steril. 95, 203–209 (2011).
  Article CAS PubMed Google Scholar
• Donesky, B. W. & Adashi, E. Y. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil. Steril. 63, 439–463 (1995).
  Article CAS PubMed Google Scholar
• Farquhar, C., Brown, J. & Marjoribanks, J. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst. Rev. 6, CD001122 (2012).
  Google Scholar
• Abu Hashim, H., Al-Inany, H., De Vos, M. & Tournaye, H. Three decades after Gjonnaess's laparoscopic ovarian drilling for treatment of PCOS; what do we know? An evidence-based approach. Arch. Gynecol. Obstetr. 288, 409–422 (2013).
  Article Google Scholar
• Koulouri, O. & Conway, G. S. A systematic review of commonly used medical treatments for hirsutism in women. Clin. Endocrinol. (Oxf.) 68, 800–805 (2008).
  Article CAS Google Scholar
• Yildiz, B. O. Assessment, diagnosis and treatment of a patient with hirsutism. Nat. Clin. Prac. Endocrinol. Metab. 4, 294–300 (2008).
  Article Google Scholar
• Swiglo, B. A. et al. Clinical review: antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J. Clin. Endocrinol. Metab. 93, 1153–1160 (2008).
  Article PubMed Google Scholar
• van Zuuren, E. J., Fedorowicz, Z., Carter, B. & Pandis, N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database Syst. Rev. 4, CD010334 (2015).
  Google Scholar
• Venturoli, S. et al. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. J. Clin. Endocrinol. Metab. 84, 1304–1310 (1999).
  Article CAS PubMed Google Scholar
• Escobar-Morreale, H. F. et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum. Reprod. Update 18, 146–170 (2012).
  Article CAS PubMed Google Scholar
• Townsend, K. A. & Marlowe, K. F. Relative safety and efficacy of finasteride for treatment of hirsutism. Ann. Pharmacother. 38, 1070–1073 (2004).
  Article CAS PubMed Google Scholar
• Moghetti, P. et al. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial. J. Clin. Endocrinol. Metab. 85, 89–94 (2000). This randomized controlled trial clearly demonstrates the positive effect and comparability of androgen blockade on hirsutism in PCOS.
  CAS PubMed Google Scholar
• Balfour, J. A. & McClellan, K. Topical eflornithine. Am. J. Clin. Dermatol. 2, 197–201; discussion 202 (2001).
  Article CAS PubMed Google Scholar
• Lizneva, D., Gavrilova-Jordan, L., Walker, W. & Azziz, R. Androgen excess: investigations and management. Best Pract. Res. Clin. Obstet. Gynaecol.http://dx.doi.org/10.1016/j.bpobgyn.2016.05.003 (2016).
• Boomsma, C. M. et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum. Reprod. Update 12, 673–683 (2006).
  Article CAS PubMed Google Scholar
• Legro, R. S. et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 356, 551–566 (2007). This is the first large randomized controlled trial to demonstrate the relative inferiority of metformin as a primary ovulatory agent in PCOS.
  Article CAS PubMed Google Scholar
• Legro, R. S. et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 371, 119–129 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zain, M. M., Jamaluddin, R., Ibrahim, A. & Norman, R. J. Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil. Steril. 91, 514–521 (2009).
  Article CAS PubMed Google Scholar
• Sagle, M. A., Hamilton-Fairley, D., Kiddy, D. S. & Franks, S. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril. 55, 56–60 (1991).
  Article CAS PubMed Google Scholar
• Polson, D. W., Mason, H. D., Saldahna, M. B. & Franks, S. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 26, 205–212 (1987).
  Article CAS Google Scholar
• Homburg, R. et al. Clomifene citrate or low-dose FSH for the first-line treatment of infertile women with anovulation associated with polycystic ovary syndrome: a prospective randomized multinational study. Hum. Reprod. 27, 468–473 (2012).
  Article CAS PubMed Google Scholar
• Solnik, M. J. in Te Linde's Atlas of Gynecologic Surgery (eds Cundiff, G. W., Azziz, R. & Bristow, R. E. ) 217–222 (Lippincott Williams & Wilkins, 2013).
  Google Scholar
• Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil. Steril. 89, 505–522 (2008).
  Article Google Scholar
• Api, M. Is ovarian reserve diminished after laparoscopic ovarian drilling? Gynecol. Endocrinol. 25, 159–165 (2009).
  Article CAS PubMed Google Scholar
• Nahuis, M. J. et al. Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. Hum. Reprod. 26, 1899–1904 (2011).
  Article CAS PubMed Google Scholar
• Cha, K. Y. et al. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization–embryo transfer. Fertil. Steril. 83, 1461–1465 (2005).
  Article PubMed Google Scholar
• Siristatidis, C. et al. In vitro maturation in women with versus without polycystic ovarian syndrome: a systematic review and meta-analysis. PLoS ONE 10, e0134696 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Walls, M. L. et al. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes. Hum. Reprod. 30, 88–96 (2015).
  Article CAS PubMed Google Scholar
• Shi, Y. et al. Live birth after fresh embryo transfer versus elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical trial. Trials 15, 154 (2014).
  Article PubMed PubMed Central Google Scholar
• Tang, T., Glanville, J., Orsi, N., Barth, J. H. & Balen, A. H. The use of metformin for women with PCOS undergoing IVF treatment. Hum. Reprod. 21, 1416–1425 (2006).
  Article CAS PubMed Google Scholar
• Tso, L. O., Costello, M. F., Albuquerque, L. E., Andriolo, R. B. & Freitas, V. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst. Rev. 2, CD006105 (2009).
  Google Scholar
• McHorney, C. A. Health status assessment methods for adults: past accomplishments and future challenges. Annu. Rev. Public Health 20, 309–335 (1999).
  Article CAS PubMed Google Scholar
• Li, Y. et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil. Steril. 96, 452–458 (2011).
  Article PubMed Google Scholar
• Cronin, L. et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J. Clin. Endocrinol. Metab. 83, 1976–1987 (1998). The authors of this article developed the first PCOS-dedicated health-related QOL questionnaire for PCOS.
  CAS PubMed Google Scholar
• Barnard, L. et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum. Reprod. 22, 2279–2286 (2007).
  Article CAS PubMed Google Scholar
• Hahn, S. et al. Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality. Hum. Reprod. 21, 1925–1934 (2006).
  Article CAS PubMed Google Scholar
• Ladson, G. et al. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil. Steril. 95, 1059–1066.e7 (2011).
  Article CAS PubMed Google Scholar
• Harris-Glocker, M., Davidson, K., Kochman, L., Guzick, D. & Hoeger, K. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. Fertil. Steril. 93, 1016–1019 (2010).
  Article PubMed Google Scholar
• Cinar, N., Harmanci, A., Demir, B. & Yildiz, B. O. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study. Hum. Reprod. 27, 1840–1845 (2012).
  Article CAS PubMed Google Scholar
• Deeks, A. A., Gibson-Helm, M. E., Paul, E. & Teede, H. J. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum. Reprod. 26, 1399–1407 (2011).
  Article CAS PubMed Google Scholar
• Elsenbruch, S. et al. Determinants of emotional distress in women with polycystic ovary syndrome. Hum. Reprod. 21, 1092–1099 (2006).
  Article PubMed Google Scholar
• Liu, D. M. et al. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome. Hum. Reprod. 29, 2764–2772 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Coviello, A. D., Sam, S., Legro, R. S. & Dunaif, A. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J. Clin. Endocrinol. Metab. 94, 4361–4366 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Recabarren, S. E. et al. Metabolic profile in sons of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 93, 1820–1826 (2008).
  Article CAS PubMed Google Scholar
• Baillargeon, J. P. & Carpentier, A. C. Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects. Diabetologia 50, 2424–2432 (2007).
  Article PubMed PubMed Central Google Scholar
• Fraser, G. L., Ramael, S., Hoveyda, H. R., Gheyle, L. & Combalbert, J. The NK3 receptor antagonist ESN364 suppresses sex hormones in men and women. J. Clin. Endocrinol. Metab. 101, 417–426 (2016).
  Article CAS PubMed Google Scholar
• Azziz, R., Dumesic, D. A. & Goodarzi, M. O. Polycystic ovary syndrome: an ancient disorder? Fertil. Steril. 95, 1544–1548 (2011).
  Article PubMed Google Scholar
• Sir-Petermann, T. et al. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92, 4637–4642 (2007).
  Article CAS PubMed Google Scholar
• Sir-Petermann, T. et al. Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 94, 1923–1930 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Maliqueo, M. et al. Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 94, 3282–3288 (2009).
  Article CAS PubMed Google Scholar
• Battaglia, C. et al. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum. Reprod. 17, 771–776 (2002).
  Article PubMed Google Scholar
• Ibanez, L. et al. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J. Clin. Endocrinol. Metab. 76, 1599–1603 (1993).
  CAS PubMed Google Scholar
• Meas, T. et al. Endocrine consequences of premature pubarche in post-pubertal Caucasian girls. Clin. Endocrinol. (Oxf.) 57, 101–106 (2002).
  Article Google Scholar
• McCartney, C. R. et al. The association of obesity and hyperandrogenemia during the pubertal transition in girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J. Clin. Endocrinol. Metab. 91, 1714–1722 (2006).
  Article CAS PubMed Google Scholar
• van Hooff, M. H. et al. Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years. Hum. Reprod. 19, 383–392 (2004). This study demonstrates the predictive nature of the degree of menstrual dysfunction, particularly for persistent menstrual dysfunction in adolescents.
  Article CAS PubMed Google Scholar
• Wiksten-Almstromer, M., Hirschberg, A. L. & Hagenfeldt, K. Prospective follow-up of menstrual disorders in adolescence and prognostic factors. Acta Obstetricia Gynecol. Scand. 87, 1162–1168 (2008).
  Article Google Scholar
• Fanelli, F. et al. Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women. J. Clin. Endocrinol. Metab. 98, 3058–3067 (2013).
  Article CAS PubMed Google Scholar
• Villarroel, C. et al. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents. Gynecol. Endocrinol. 31, 625–629 (2015).
  Article CAS PubMed Google Scholar
• Ibanez, L. et al. Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth. J. Clin. Endocrinol. Metab. 93, 196–199 (2008).
  Article CAS PubMed Google Scholar
• Cresswell, J. L. et al. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 350, 1131–1135 (1997).
  Article CAS PubMed Google Scholar
• DeFronzo, R. A., Bonadonna, R. C. & Ferrannini, E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15, 318–368 (1992).
  Article CAS PubMed Google Scholar